TheraRadar
← Back
Data updated: Mar 29, 2026

Takeda

ImmunologyOncologyGastroenterology
Big Pharma

Takeda is a major pharmaceutical company focused on Immunology, Oncology, Gastroenterology. Key products include ENTYVIO.

1945
Since
68
Drugs
-
Trials
23
Approved (2yr)

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Immunology 40%
3 drugs Phase 3: 41 Phase 2: 11 Phase 1: 16
Oncology 22%
6 drugs Phase 3: 6 Phase 2: 15 Phase 1: 32
Gastroenterology 21%
4 drugs Phase 3: 16 Phase 2: 6 Phase 1: 14
Neurology 9%
1 drugs Phase 3: 8 Phase 2: 5 Phase 1: 3
Metabolic 8%
3 drugs Phase 3: 4 Phase 1: 10

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...